Top compounds associated with response to EFCAB13


Feature Type Standardized
Nominal ANOVA
mRNA HC-067047 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA ML320 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.3
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.032 0.3
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA PLX4720 CCLE pan-cancer AAC 0.045 0.3
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC -0.052 0.3
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.033 0.3
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.052 0.3
Download CSV